BLT benitec biopharma limited

Ann: App 4E / Full Year Statutory Accounts, page-6

  1. 4,015 Posts.
    lightbulb Created with Sketch. 127
    This statement on HBV seems a little inconsistent with that made in the last IPO prospectus. I am sure the prospectus said that the AMD program would be taken to the clinical stage but there are insufficient funds to do the same for HBV. I guess the company is expecting another capital raising in order to progress HBV.

    I also note that the $2.7M for the Tribetarna trial is still in the Current Assets.
    Last edited by Hoyland: 31/08/15
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.